© 2021 Western New York Public Broadcasting Association

140 Lower Terrace
Buffalo, NY 14202

Mailing Address:
Horizons Plaza P.O. Box 1263
Buffalo, NY 14240-1263

Buffalo Toronto Public Media | Phone 716-845-7000
WBFO Newsroom | Phone: 716-845-7040
Your NPR Station
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Health & Wellness

Nielsen provides perspective on Johnson & Johnson vaccine

nielsen_2.jpg

The distribution of the Johnson & Johnson COVID-19 vaccine may be on pause, says Dr. Nancy Nielsen, but its benefits are still worth considering "Remember, we've had 7 million people that have already gotten it." The former President of the American Medical Association is applauding the decision to halt distribution, calling the move "government at its best." As health officials review the data, Nielsen offers some thoughts for those who have already received the vaccine.

If the vaccine was provided more than three weeks ago, Nielsen assures there are no concerns. More recent recipients should notify their physicians if they have "symptoms of severe headache" or "severe abdominal pain--nausea, vomiting, that sort of thing."

The Senior Associate Dean for Health Policy at UB's Jacobs School of Medicine and Biomedical Sciences plans to watch unfolding analysis of the controversial vaccine. She shared some thoughts moving forward.

"What is the risk of dying of COVID? It's one in 586 people," Nielsen said.

"That's far higher than the risk of getting a blood clot from J&J (vaccine)."

To this point, six women who had received the vaccine have developed blood clots in the brain. One person died. Another is in critical condition.

"All these patients also had low platelets, those elements in the blood that promote clotting," Nielsen pointed out.  

"Low platelets and the very unusual blood clotting is what drew the attention of regulators."